Novartis Investigative Site

Passo Fundo 99010-080

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Relapsing-remitting Multiple Sclerosis (RRMS)

Studies at this site

• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone — Stopped early